Palvella Therapeutics to expand Phase 3 SELVA trial to include younger patients
Palvella Therapeutics (PVLA) announced that it will expand SELVA, the Company’s Phase 3 clinical trial of QTORIN 3.9% rapamycin anhydrous gel ...
Clinical Trials Arena on MSN2d
Novo Nordisk’s haemophilia A drug stops bleeds in 74% of children
Novo Nordisk’s haemophilia A therapy Mim8 stopped bleeding completely in 74.3% of children in a Phase III trial. The ...
Fact Check: Moderna began clinical trials of COVID vaccine in 2020, not 2017
Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
Abandoned in the Middle of Clinical Trials, Because of a Trump Order
The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their ...
MyChesCo on MSN4d
Aprea Therapeutics Strengthens Patent Portfolio to Advance Oncology Innovation
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) has announced significant advancements in its intellectual property ...
Le Lézard4d
Labcorp Announces 2024 Fourth Quarter and Full Year Results
Revenue: Q4 of $3.33 billion vs $3.03 billion; Full year of $13.01 billion vs $12.16 billionDiluted EPS: Q4 of $1.70 vs $(1.95); Full year of $8.84 vs ...